These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38791414)

  • 1. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
    Fellhofer-Hofer J; Franz C; Vey JA; Kahlert C; Kalkum E; Mehrabi A; Halama N; Probst P; Klupp F
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
    Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
    Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
    Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
    Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
    Jiang Q; Sun Y; Liu X
    Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
    Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
    Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
    Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
    Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
    Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
    PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
    Qiu L; Xu Y; Xu H; Yu B
    BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer.
    Xu C; Zheng L; Li D; Chen G; Gu J; Chen J; Yao Q
    Life Sci; 2018 Sep; 208():333-340. PubMed ID: 29719205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Idos GE; Kwok J; Bonthala N; Kysh L; Gruber SB; Qu C
    Sci Rep; 2020 Feb; 10(1):3360. PubMed ID: 32099066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
    Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
    Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.
    Weixler B; Renetseder F; Facile I; Tosti N; Cremonesi E; Tampakis A; Delko T; Eppenberger-Castori S; Tzankov A; Iezzi G; Kettelhack C; Soysal SD; von Holzen U; Spagnoli GC; Terracciano L; Tornillo L; Droeser RA; Däster S
    Cell Oncol (Dordr); 2017 Dec; 40(6):609-619. PubMed ID: 28936810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis.
    Zhang Z; Ni C; Chen W; Wu P; Wang Z; Yin J; Huang J; Qiu F
    BMC Cancer; 2014 Jan; 14():49. PubMed ID: 24475985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.
    Chen Q; Zhong T
    Drug Des Devel Ther; 2015; 9():5115-22. PubMed ID: 26379424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
    Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
    Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
    Xu TP; Shen H; Liu LX; Shu YQ
    Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
    Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.